DYN- Dyne Therapeutics, Inc.

Name: Dyne Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Dyne Therapeutics, Inc. (DYN) has 7 insiders with recent SEC Form 4 filings, including 2 buys and 9 sells. DYN is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Kersten Dirk	5.28M	$110.10M	-
Dir	Rhodes Jason P	1.16M	$24.19M	-
CEO	Cox John	368.2K	$7.68M	-2,683
Other	Kerr Douglas	169.2K	$3.53M	-887
Other	Friedl-Naderer Johanna	154.2K	$3.22M	-145

Activity

Buys and sells only

Transactions

10 filings · page 15

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 14, 2023	High Susanna Gatti66	Chief Operating Officer	Sell	1,559	$13.33	$20,781.47	-1.4%	-7.3%	+105.7%
Mar 14, 2023	Farwell Wildon55	Chief Medical Officer	Sell	7,441	$13.33	$99,188.53	-7.4%	-7.3%	+105.7%
Mar 14, 2023	Brumm Joshua T54	See Remarks	Sell	7,318	$13.33	$97,548.94	-2.2%	-7.3%	+105.7%
Mar 14, 2023	Beskrovnaya Oxana58	Chief Scientific Officer	Sell	1,416	$13.33	$18,875.28	-1.6%	-7.3%	+105.7%
Mar 14, 2023	Scalzo Richard William58	See Remarks	Sell	1,311	$13.33	$17,475.63	-2.3%	-7.3%	+105.7%
Mar 14, 2023	McNeill Jonathan55	See Remarks	Sell	2,209	$13.18	$29,115.97	-1.6%	-7.3%	+105.7%
Jan 18, 2023	McNeill Jonathan55	See Remarks	Sale+OE	10,000	$14.03	$140,300.00	-12.9%	-29.6%	+17.2%
Jan 9, 2023	McNeill Jonathan55	See Remarks	Sell	30,150	$11.57	$348,835.50	-30.8%	-23.0%	+63.9%
Dec 12, 2022	Atlas Venture Opportunity Fund Ii, L.P.	10% Owner	Buy	934,581	$10.70	$10,000,016.70	New	+13.1%	-5.9%
Dec 12, 2022	Rhodes Jason P78	Director	Buy	934,581	$10.70	$10,000,016.70	New	+13.1%	-5.9%

← PrevPage 15Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC